Clinical Trial: Ranibizumab Therapy for Choroidal Neovascularization (CNV) Asociated With Angioid Streaks

Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional




Official Title: Ranibizumab Therapy for Choroidal Neovascularization Associated With Angioid Streaks

Brief Summary: The purpose of this study is to determine whether injections of ranibizumab into the eye are safe and well tolerated when given to subjects in multiple doses.